Press release
Phosphatidylinositol 4,5 Bisphosphate Market Key Players – AstraZeneca Plc, Bayer AG, Curis Inc, Eli Lilly & Co and Genentech Inc Analysis & Forecast 2017 to 2022
Phosphatidylinositol 4,5 Bisphosphate
Phosphatidylinositol 4,5 Bisphosphate
Overview
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Alpha Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Alpha or Phosphoinositide 3 Kinase Catalytic Alpha Polypeptide or Serine/Threonine Protein Kinase PIK3CA or PIK3CA or EC 2.7.11.1 or EC 2.7.1.153) - The phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit alpha also called p110α is a protein encoded by the PIK3CA gene.
It is involved in cell growth, survival, proliferation, motility and morphology. It participates in cellular signaling in response to various growth factors. It is involved in the activation of AKT1 and signaling via insulin receptor substrate (IRS) proteins. It is essential in endothelial cell migration during vascular development through VEGFA signaling. It is required for lymphatic vasculature development.
Click here for sample report @ https://www.wiseguyreports.com/sample-request/629561-phosphatidylinositol-4-5-bisphosphate-protein-kinase-pik3
Top Companies mentioned
AstraZeneca Plc
Bayer AG
Curis Inc
Eli Lilly and Co
Genentech Inc
GlaxoSmithKline Plc
Millennium Pharmaceuticals Inc
Novartis AG
Onconova Therapeutics Inc
PIQUR Therapeutics AG
Phosphatidylinositol 4,5 Bisphosphate Industry Major Outlook
Pharmaceutical and Healthcare latest pipeline guide Phosphatidylinositol 4,5 Bisphosphate - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Phosphatidylinositol 4,5 Bisphosphate , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Alpha Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Alpha or Phosphoinositide 3 Kinase Catalytic Alpha Polypeptide or Serine/Threonine Protein Kinase PIK3CA or PIK3CA or EC 2.7.11.1 or EC 2.7.1.153) pipeline Target constitutes close to 19 molecules.
Out of which approximately 17 molecules are developed by companies and remaining by the universities/institutes. The molecules developed by companies in Phase III, Phase II, Phase I and Preclinical stages are 2, 5, 3 and 7 respectively.
Phosphatidylinositol 4,5 Bisphosphate pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Phosphatidylinositol 4,5 Bisphosphate - Competitive Analysis
Key players are making innovative developments in Phosphatidylinositol 4,5 Bisphosphate industry. The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Phosphatidylinositol 4,5 Bisphosphate.
The pipeline guide reviews pipeline therapeutics for Phosphatidylinositol 4,5 Bisphosphate by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Phosphatidylinositol 4,5 Bisphosphate therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Phosphatidylinositol 4,5 Bisphosphate therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Phosphatidylinositol 4,5 Bisphosphate.
.Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/629561-phosphatidylinositol-4-5-bisphosphate-protein-kinase-pik3
Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.
WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Phosphatidylinositol 4,5 Bisphosphate Market Key Players – AstraZeneca Plc, Bayer AG, Curis Inc, Eli Lilly & Co and Genentech Inc Analysis & Forecast 2017 to 2022 here
News-ID: 951047 • Views: …
More Releases from WiseGuy Research consultants Pvt Ltd.
Beauty Drinks Market and its Future Outlook and Trend During the Period of 2019 …
Global Beauty Drinks Market Research Report 2019
Summary: -
Wiseguyreports.Com Adds “Beauty Drinks - Market Demand, Growth, Opportunities, Manufacturers and Analysis of Top Key Players to 2025” To Its Research Database.
Overview:
Beauty drinks refer to both carbonated and non-carbonated beverages, which is used to retain natural beauty during aging. The beauty drinks contain various vitamins, minerals, amino acids, and antioxidants. It aids to support diets by encouraging metabolism. The global beauty drinks market…
Global Capsule Endoscopy Treatment Solutions Market 2020: key Vendors, Trends, A …
Summary
A New Market Study, titled “Capsule Endoscopy Treatment Solutions Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.
This report provides in depth study of “Capsule Endoscopy Treatment Solutions Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Capsule Endoscopy Treatment Solutions Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such…
Data Center Colocation Market 2019: Size, Share, Demand, Trends, Growth and 2025 …
Global Data Center Colocation Industry
New Study On “2019-2025 Data Center Colocation Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database
Data center operators face an increasing need for scalable data center infrastructure, which enables the scaling of critical data center components as and when the demand increases. The data center colocation provides data center space, along with the power and cooling infrastructure, which address…
Temperature Logger Market 2019 Trends, Research, Analysis & Review Forecast 2025
Global Temperature Logger Industry
New Study On “2019-2025 Temperature Logger Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database
This report studies the global Temperature Logger market status and forecast, categorizes the global Temperature Logger market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).
The…
More Releases for Phosphatidylinositol
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Ma …
The global Phosphatidylinositol 4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta Isoform (PIK3CB) market was valued at approximately USD 140 million in 2023 and is projected to reach around USD 305 million by 2033, growing at a compound annual growth rate (CAGR) of approximately 8.1% from 2024 to 2033.
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market Overview
The Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market growth is fueled by…
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Ma …
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market was valued at USD Billion in 2023 and is expected to grow at a CAGR of 27% between 2024 and 2031. Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market research report is one of the effective ways to target customers and satisfy their growing needs as it gathers all the significant market data. It allows tracking future business…
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Ma …
The global phosphatidylinositol 4,5 bisphosphate 3 kinase catalytic subunit beta isoform market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). This gene encodes an isoform of the catalytic subunit of phosphoinositide 3-kinase (PI3K) and is important in signalling pathways that involve receptors on the outer membrane of eukaryotic cells. The major factor driving the market growth include the rising prevalence of cancer across the globe.…
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Ma …
In 2018, the global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform.
This report focuses on…
Phosphatidylinositol 3-Kinase Inhibitors - Pipeline, Clinical Trials and Key Pla …
The PI3K inhibitors pipeline analysis report covers approximately 37 active drug candidates in different stages of development.
Phosphatidylinositol 3-kinases (PI3K) are lipid kinases that are involved in cell regulation, including cell survival, proliferation and differentiation. They act as intermediate molecules in PI3K/AKT/mTOR signaling pathway by sending chemical messengers from cell surface to cytoplasm. These signals activate multiple effector kinase pathways, resulting in survival and growth of normal cells. Phosphatidylinositol 3-kinases is…
Global Market Study On Phosphatidylinositol 4, 5 Bisphosphate 3 Kinase Catalytic …
Orbisreserach.Com Adds “H1 Phosphatidylinositol 4, 5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform (Phosphatidylinositol 4, 5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2. 7. 1. 153) Market Pipeline Review 2017 Trend Analysis Report Report” To Its Research Database
Description:
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Beta or PIK3CB or EC 2.7.1.153) - Phosphatidylinositol-4, 5-bisphosphate…
